The clues from standard testing are sufficient to rapidly initiate aggressive treatment to reduce or prevent kidney destruction.
Nearly 20% of patients with multiple myeloma have a form in which they make extreme quantities of one component of the abnormal antibody they are producing, and these so-called “free monoclonal light chains” pile up and damage the kidneys...